Morbidity of Chronic Obstructive Pulmonary Disease in Colombia. Results of the study SANEPOC-2
DOI:
https://doi.org/10.31053/1853.0605.v75.n1.16617Keywords:
COPD, Morbidities, spirometry, Colombia, symptomsAbstract
Objective: to relate the morbidities of patients belonging to the COPD program of a health institution in Anserma, Caldas (Colombia). Material and Methods: a descriptive study was presented with a sample of 51 patients who underwent exploratory spirometry, the findings were contrasted with the main commodities reported by the patients or the Medical Record through descriptive and inferential statistics. Results: 50% of the evaluated population had at least one recorded comorbidity; the main morbidity found was Arterial Hypertension followed by Chronic Kidney Disease; an associated behavior was found between the GOLD classification and the presence of symptoms with non-statistically significant values; no statistically significant association was found between comorbidities and spirometric values. Conclusions: new research is needed that clearly values causality in the Colombian population.
Downloads
References
Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2012, 187(4):347–365.
Menezes Ana y cols. PROYECTO LATINOAMERICANO DE
INVESTIGACIÓN EN OBSTRUCCIÓN PULMONAR. Libro oficial. Capítulo
www.platino-alat.org
WORLD HEALTH STATISTICS2014. WORLD HEALTH
ORGANIZATIONWHO Library Cataloguing-in-Publication Data. ISBN 978 92 4 069267 1 (PDF)
AnaMBMenezes, Cesar G Victora, Rogelio Perez-Padilla and the PLATINO Team. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities.
BMC Medical Research Methodology 2004, 4:15 doi:10.1186/1471-2288-415
Buist Sonia McBurnie Mary Ann et al. International variation in the prevalence of COPD(The BOLD Study): a population-based prevalence studyLancet 2007; 370: 741–50
Araya Marcela et al. Calidad de las espirometrías en un estudio epidemiológico de terreno. Factores determinantes de la necesidad de repetir el examen en el estudio Platino-Chile. Rev Chil Enf Respir 2005; 21: 155-163
Buist Sonia McBurnie Mary Ann et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study Lancet 2007; 370: 741–50
VestboJ.Anderson W. et al.Evaluation of COPD Longitudinallyto Identify
Predictive SurrogateEnd-points (ECLIPSE).EurRespir J 2008; 31: 869–
DOI: 10.1183/09031936.00111707CopyrightERS Journals Ltd 2008
American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107– 1136
Caballero Andres et al. Prevalence of COPD in Five ColombianCities Situated at Low, Medium, andHigh Altitude (PREPOCOL
Study)*.CHEST/133/2/ FEBRUARY, 2008
Noriane a. Sievi, oliver senn,thomas brack et al.Impact of comorbidities on physical activity in COPD. Respirology (2015) 20, 413–418 © 2015 Asian Pacific Society of Respirology
Bartolome R. Celli, Claudia G. Cote, Jose M. Marin et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. n engl j med 350;10 www.nejm.org march 4, 2004
Irene Torres-Sánchez, Elisabeth Rodríguez-Alzueta, Irene Cabrera-Martos et al. Cognitive impairment in COPD: a systematic review. J Bras Pneumol. 2015;41(2):182-190. http://dx.doi.org/10.1590/S1806-37132015000004424
Fausto Aloísio Pedrosa Pimentaa, Maria Aparecida Camargos Bicalhob, Marco Aurélio Romano-Silva.Chronic diseases, cognition, functional decline, and the Charlson index in elderly people with dementia. REV ASSOC MED BRAS. 2013;59(4):326-334
Black-Shinn, Kinney GL, Wise AL, Regan EA, Make B y cols. Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD. 2014 Sep;11(5):546-51. doi: 10.3109/15412555.2014.898029. Epub 2014 May 15.
Craig P Hersh1, Barry J Make, David A Lynch, et al.Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus.
Hersh et al. BMC Pulmonary Medicine 2014, 14:164
http://www.biomedcentral.com/1471-2466/14/164
Irene Torres-Sánchez, Marie Carmen Valenza, Fernando Carrasco et al. Alteraciones endocrinometabólicas en la enfermedad pulmonar obstructiva crónica. Nutr Hosp. 2013;28(4):1022-1030 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318
Calverley P, Anderson J, Celli B, Ferguson G, Jenkins C, Jones P et al. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. N Engl J Med 2007; 356: 775-89.
Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R, ECLIPSE Investigators: Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008, 31(4):869–873.
Downloads
Published
How to Cite
Issue
Section
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
